Diabetic polyneuropathy (DPN) is a major contributor for morbidity in diabetes; however, up to this day, there is a lack of sufficient strategies to prevent this disorder especially in patients suffering from type 2 diabetes (T2D). Specifically, it remains controversially discussed if a lowering of serum cholesterol has beneficial effects on the course of T2D DPN. Using in vivo high resolution magnetic resonance neurography in 100 type 2 diabetes patients with and without DPN, we found that lowering of serum cholesterol, especially lowering of LDL, is strongly associated with an increase in visible nerve damage. We further found a significant correlation between the amount of nerve damage and the patients’ statin dose. In T2D patients, this effect is potentially relevant for therapies that promote an aggressive lowering of serum cholesterol.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords